Involvement of the Bone Marrow by Dedifferentiated Liposarcoma: The First Case Report.
- Author:
Hyun Woo LEE
1
;
Younghoon KIM
;
Jae Hyun LEE
;
Hyerim HA
;
Han Sol CHOI
;
Ha Kyeong WON
;
Hyun CHANG
Author Information
1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Liposarcoma;
Bone marrow;
Neoplasm metastasis;
Doxorubicin
- MeSH:
Adult;
Biopsy;
Bone Marrow*;
Disease Progression;
Doxorubicin;
Drug Therapy;
Humans;
Liposarcoma*;
Male;
Neoplasm Metastasis;
Positron-Emission Tomography;
Radiotherapy;
Thrombocytopenia
- From:Soonchunhyang Medical Science
2014;20(2):184-187
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We report on a first case of bone marrow metastasis by dedifferentiated liposarcoma. A 39-year-old male diagnosed with retroperitoneal dedifferentiated liposarcoma underwent surgery and postoperative radiotherapy. In spite of radiotherapy, his whole-body positron emission tomography showed high uptake in multiple bone metastasis. With thrombocytopenia, bone scan suggested bone marrow involvement. After bone marrow biopsy, bone marrow metastasis by dedifferentiated liposarcoma was finally confirmed. He was administered with systemic chemotherapy with doxorubicin. But he died 3 months after chemotherapy due to disease progression. This case revealed that in a patient of unexplained cytopenia with dedifferentiated liposarcoma, bone marrow metastasis should be in consideration.
